We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » EMA Urges Makers of Urokinase Drugs to Estimate Pathogen Contamination Probability
EMA Urges Makers of Urokinase Drugs to Estimate Pathogen Contamination Probability
While advances in technology have improved the purity profile of urokinase-based drugs, EU regulators are urging makers of these drugs to estimate the risk that an individual dose of a product might be contaminated with pathogens.